Listed

KORU Medical Systems, Inc.

KRMDNasdaqCIK 704440HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$12.0m, Q2 FY2026
Operating income$627.0k, Q2 FY2026
Net income$252.4k, Q2 FY2026
KORU Medical Systems, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m7.0Revenue, Q3 FY2023, three months to 2023-09-30$7.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure7.2Revenue, Q4 FY2023, three months to 2023-12-31$7.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure8.2Revenue, Q1 FY2024, three months to 2024-03-31$8.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure8.4Revenue, Q2 FY2024, three months to 2024-06-30$8.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure8.2Revenue, Q3 FY2024, three months to 2024-09-30$8.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure8.8Revenue, Q4 FY2024, three months to 2024-12-31$8.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure9.6Revenue, Q1 FY2025, three months to 2025-03-31$9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure10.2Revenue, Q2 FY2025, three months to 2025-06-30$10.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure10.4Revenue, Q3 FY2025, three months to 2025-09-30$10.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure10.9Revenue, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure11.8Revenue, Q1 FY2026, three months to 2026-03-31$11.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure12.0Revenue, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Cost of revenue$m2.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure2.9Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure3.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure3.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$3.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure3.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$3.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure3.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$3.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure3.6Cost of revenue, Q1 FY2025, three months to 2025-03-31$3.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure3.7Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure4.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure4.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$4.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure4.5Cost of revenue, Q1 FY2026, three months to 2026-03-31$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure4.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$4.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Gross profit$m4.3Gross profit, Q3 FY2023, three months to 2023-09-30$4.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure4.3Gross profit, Q4 FY2023, three months to 2023-12-31$4.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure5.1Gross profit, Q1 FY2024, three months to 2024-03-31$5.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure5.5Gross profit, Q2 FY2024, three months to 2024-06-30$5.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure5.2Gross profit, Q3 FY2024, three months to 2024-09-30$5.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure5.6Gross profit, Q4 FY2024, three months to 2024-12-31$5.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure6.0Gross profit, Q1 FY2025, three months to 2025-03-31$6.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure6.5Gross profit, Q2 FY2025, three months to 2025-06-30$6.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure6.3Gross profit, Q3 FY2025, three months to 2025-09-30$6.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure6.8Gross profit, Q4 FY2025, three months to 2025-12-31$6.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure7.2Gross profit, Q1 FY2026, three months to 2026-03-31$7.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure7.8Gross profit, Q2 FY2026, three months to 2026-06-30$7.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Research and development$m1.3Research and development, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure1.3Research and development, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure1.5Research and development, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure1.1Research and development, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure1.5Research and development, Q3 FY2024, three months to 2024-09-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure1.1Research and development, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure1.1Research and development, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure1.2Research and development, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure0.9Research and development, Q3 FY2025, three months to 2025-09-30$933.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure1.1Research and development, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure1.3Research and development, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure1.1Research and development, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Selling, general and administrative$m4.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$4.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure5.0Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$5.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure5.4Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$5.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure5.3Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$5.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure5.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure5.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$5.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure6.0Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$6.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure5.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$5.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure6.0Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$6.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure6.0Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$6.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure6.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$6.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure5.9Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Operating income$m(1.8)Operating income, Q3 FY2023, three months to 2023-09-30−$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure(2.2)Operating income, Q4 FY2023, three months to 2023-12-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure(2.0)Operating income, Q1 FY2024, three months to 2024-03-31−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure(1.2)Operating income, Q2 FY2024, three months to 2024-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure(1.7)Operating income, Q3 FY2024, three months to 2024-09-30−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(1.6)Operating income, Q4 FY2024, three months to 2024-12-31−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure(1.2)Operating income, Q1 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure(0.3)Operating income, Q2 FY2025, three months to 2025-06-30−$312.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure(0.9)Operating income, Q3 FY2025, three months to 2025-09-30−$867.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(0.5)Operating income, Q4 FY2025, three months to 2025-12-31−$547.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure(0.9)Operating income, Q1 FY2026, three months to 2026-03-31−$864.9k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure0.6Operating income, Q2 FY2026, three months to 2026-06-30$627.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m(0.3)Income tax, Q3 FY2023, three months to 2023-09-30−$300.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure5.4Income tax, Q4 FY2023, three months to 2023-12-31$5.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$17.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-09-30−$150. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$4.7k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$5.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Net income$m(1.4)Net income, Q3 FY2023, three months to 2023-09-30−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure(7.5)Net income, Q4 FY2023, three months to 2023-12-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure(1.9)Net income, Q1 FY2024, three months to 2024-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(1.0)Net income, Q2 FY2024, three months to 2024-06-30−$988.7k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(1.6)Net income, Q3 FY2024, three months to 2024-09-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(1.6)Net income, Q4 FY2024, three months to 2024-12-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure(1.2)Net income, Q1 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure(0.2)Net income, Q2 FY2025, three months to 2025-06-30−$206.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure(0.8)Net income, Q3 FY2025, three months to 2025-09-30−$778.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure(0.5)Net income, Q4 FY2025, three months to 2025-12-31−$486.9k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Net income, Q1 FY2026, three months to 2026-03-31−$807.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure0.3Net income, Q2 FY2026, three months to 2026-06-30$252.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Diluted EPS$ per share(0.03)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figurenot reported0.04Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure0.02Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure0.03Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure0.02Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure0.01Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Basic EPS$ per share(0.03)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figurenot reported0.04Basic EPS, Q1 FY2024, three months to 2024-03-31$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure(0.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure(0.03)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figurenot reported(0.03)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figurenot reportednot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure0.01Basic EPS, Q2 FY2026, three months to 2026-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure

Balance sheet

Cash and equivalents$8.3m, Q2 FY2026
Shareholders' equity$18.1m, Q2 FY2026
KORU Medical Systems, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m10.8Cash and equivalents, Q3 FY2023, at 2023-09-30$10.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure11.5Cash and equivalents, FY2023, at 2023-12-31$11.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-12, accession 0001161697-25-000103.Report this figure10.8Cash and equivalents, Q1 FY2024, at 2024-03-31$10.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure10.5Cash and equivalents, Q2 FY2024, at 2024-06-30$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure8.8Cash and equivalents, Q3 FY2024, at 2024-09-30$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure9.6Cash and equivalents, FY2024, at 2024-12-31$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure8.7Cash and equivalents, Q1 FY2025, at 2025-03-31$8.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure8.1Cash and equivalents, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure8.5Cash and equivalents, Q3 FY2025, at 2025-09-30$8.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure8.9Cash and equivalents, FY2025, at 2025-12-31$8.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure8.8Cash and equivalents, Q1 FY2026, at 2026-03-31$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure8.3Cash and equivalents, Q2 FY2026, at 2026-06-30$8.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Current assets$m21.7Current assets, Q3 FY2023, at 2023-09-30$21.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure20.3Current assets, FY2023, at 2023-12-31$20.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-12, accession 0001161697-25-000103.Report this figure19.5Current assets, Q1 FY2024, at 2024-03-31$19.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure19.4Current assets, Q2 FY2024, at 2024-06-30$19.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure18.9Current assets, Q3 FY2024, at 2024-09-30$18.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure19.1Current assets, FY2024, at 2024-12-31$19.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure19.0Current assets, Q1 FY2025, at 2025-03-31$19.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure17.6Current assets, Q2 FY2025, at 2025-06-30$17.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure19.4Current assets, Q3 FY2025, at 2025-09-30$19.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure20.0Current assets, FY2025, at 2025-12-31$20.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure20.6Current assets, Q1 FY2026, at 2026-03-31$20.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure19.5Current assets, Q2 FY2026, at 2026-06-30$19.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Total assets$m35.4Total assets, Q3 FY2023, at 2023-09-30$35.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure28.5Total assets, FY2023, at 2023-12-31$28.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-12, accession 0001161697-25-000103.Report this figure27.5Total assets, Q1 FY2024, at 2024-03-31$27.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure27.3Total assets, Q2 FY2024, at 2024-06-30$27.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure27.4Total assets, Q3 FY2024, at 2024-09-30$27.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure27.2Total assets, FY2024, at 2024-12-31$27.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure27.2Total assets, Q1 FY2025, at 2025-03-31$27.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure25.5Total assets, Q2 FY2025, at 2025-06-30$25.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure27.1Total assets, Q3 FY2025, at 2025-09-30$27.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure28.2Total assets, FY2025, at 2025-12-31$28.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure28.6Total assets, Q1 FY2026, at 2026-03-31$28.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure28.0Total assets, Q2 FY2026, at 2026-06-30$28.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Current liabilities$m4.2Current liabilities, Q3 FY2023, at 2023-09-30$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure4.5Current liabilities, FY2023, at 2023-12-31$4.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-12, accession 0001161697-25-000103.Report this figure4.9Current liabilities, Q1 FY2024, at 2024-03-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure5.1Current liabilities, Q2 FY2024, at 2024-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure6.3Current liabilities, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure7.2Current liabilities, FY2024, at 2024-12-31$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure7.8Current liabilities, Q1 FY2025, at 2025-03-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure6.1Current liabilities, Q2 FY2025, at 2025-06-30$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure7.8Current liabilities, Q3 FY2025, at 2025-09-30$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure8.2Current liabilities, FY2025, at 2025-12-31$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure8.9Current liabilities, Q1 FY2026, at 2026-03-31$8.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure7.2Current liabilities, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Total liabilities$m7.9Total liabilities, Q3 FY2023, at 2023-09-30$7.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure8.1Total liabilities, FY2023, at 2023-12-31$8.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-12, accession 0001161697-25-000103.Report this figure8.4Total liabilities, Q1 FY2024, at 2024-03-31$8.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure8.6Total liabilities, Q2 FY2024, at 2024-06-30$8.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure9.7Total liabilities, Q3 FY2024, at 2024-09-30$9.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure10.4Total liabilities, FY2024, at 2024-12-31$10.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure10.9Total liabilities, Q1 FY2025, at 2025-03-31$10.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure9.0Total liabilities, Q2 FY2025, at 2025-06-30$9.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure10.6Total liabilities, Q3 FY2025, at 2025-09-30$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure11.2Total liabilities, FY2025, at 2025-12-31$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure11.7Total liabilities, Q1 FY2026, at 2026-03-31$11.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure9.9Total liabilities, Q2 FY2026, at 2026-06-30$9.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m27.4Shareholders' equity, Q3 FY2023, at 2023-09-30$27.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure20.4Shareholders' equity, FY2023, at 2023-12-31$20.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001161697-26-000052.Report this figure19.1Shareholders' equity, Q1 FY2024, at 2024-03-31$19.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure18.7Shareholders' equity, Q2 FY2024, at 2024-06-30$18.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure17.7Shareholders' equity, Q3 FY2024, at 2024-09-30$17.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure16.8Shareholders' equity, FY2024, at 2024-12-31$16.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure16.3Shareholders' equity, Q1 FY2025, at 2025-03-31$16.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure16.5Shareholders' equity, Q2 FY2025, at 2025-06-30$16.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure16.5Shareholders' equity, Q3 FY2025, at 2025-09-30$16.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure17.0Shareholders' equity, FY2025, at 2025-12-31$17.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure16.9Shareholders' equity, Q1 FY2026, at 2026-03-31$16.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure18.1Shareholders' equity, Q2 FY2026, at 2026-06-30$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure

Cash flow

Operating cash flow$216.1k, Q2 FY2026
Capital expenditure$107.9k, Q2 FY2026
KORU Medical Systems, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,175)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001161697-24-000441. Derived: 9-month figure less the 6-month figure.Report this figure1,097Operating cash flow, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure(347)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$346.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure11.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$11.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001161697-25-000217. Derived: 6-month figure less the 3-month figure.Report this figure(924)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$923.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001161697-25-000372. Derived: 9-month figure less the 6-month figure.Report this figure940Operating cash flow, Q4 FY2024, three months to 2024-12-31$939.6k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure(237)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$237.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure(460)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$460.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001161697-26-000189. Derived: 6-month figure less the 3-month figure.Report this figure65.5Operating cash flow, Q3 FY2025, three months to 2025-09-30$65.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001161697-25-000372. Derived: 9-month figure less the 6-month figure.Report this figure1,095Operating cash flow, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure14.7Operating cash flow, Q1 FY2026, three months to 2026-03-31$14.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure216Operating cash flow, Q2 FY2026, three months to 2026-06-30$216.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001161697-26-000189. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k212Capital expenditure, Q3 FY2023, three months to 2023-09-30$211.7k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2024-11-13, accession 0001161697-24-000441. Derived: 9-month figure less the 6-month figure.Report this figure196Capital expenditure, Q4 FY2023, three months to 2023-12-31$196.1k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-12, accession 0001161697-25-000103. Derived: 12-month figure less the 9-month figure.Report this figure133Capital expenditure, Q1 FY2024, three months to 2024-03-31$133.1k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure124Capital expenditure, Q2 FY2024, three months to 2024-06-30$124.3k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-08-06, accession 0001161697-25-000217. Derived: 6-month figure less the 3-month figure.Report this figure1,084Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001161697-25-000372. Derived: 9-month figure less the 6-month figure.Report this figure(43.6)Capital expenditure, Q4 FY2024, three months to 2024-12-31−$43.6k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure443Capital expenditure, Q1 FY2025, three months to 2025-03-31$443.4k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure28.8Capital expenditure, Q2 FY2025, three months to 2025-06-30$28.8k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001161697-26-000189. Derived: 6-month figure less the 3-month figure.Report this figure52.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$52.5k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001161697-25-000372. Derived: 9-month figure less the 6-month figure.Report this figure408Capital expenditure, Q4 FY2025, three months to 2025-12-31$407.8k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-12, accession 0001161697-26-000052. Derived: 12-month figure less the 9-month figure.Report this figure46.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$46.2k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure108Capital expenditure, Q2 FY2026, three months to 2026-06-30$107.9k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001161697-26-000189. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)49.51m, Q2 FY2026
KORU Medical Systems, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares45.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3045,038,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001161697-23-000568.Report this figure45.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3145,487,593 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0001161697-24-000226.Report this figure45.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3045,606,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001161697-24-000334.Report this figure45.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3045,639,081 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001161697-24-000441.Report this figure45.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3145,712,224 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001161697-25-000169.Report this figure45.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3045,811,373 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001161697-25-000217.Report this figure45.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3045,851,019 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure46.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3145,981,826 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure46.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3046,193,709 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure46.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3046,238,819 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001161697-25-000372.Report this figure46.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3146,364,905 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001161697-26-000108.Report this figure49.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3049,509,437 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure

Shares outstanding: 46.17mShares outstanding, period not labelled, at 2026-08-0546,171,902 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001161697-26-000189.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.